Introduction Cancer of unknown primary (CUP) is a designation given to discordant group of metastatic carcinomas for which the primary site of origin cannot be identified, despite a thorough diagnostic workup that includes a thorough medical history, complete physical examination…
Introduction In general, the role of imaging in ovarian cancer screening is limited, because gynecologic oncologists depend more on the clinical examination and tumor markers cancer antigen 125 (CA125) to make the diagnosis. Ovarian cancers are usually detected when patients…
Malignant tumors of the uterine corpus can be divided into epithelial and mesenchymal types (sarcomas). In 2019, there were an estimated 61,880 cases of cancer involving the uterine corpus in the United States, of which 3% were uterine sarcomas, with…
Introduction Cystic lesions of the pancreas include malignant and benign processes and may or may not cause clinical symptoms. The risk of malignancy in symptomatic cyst can be high, whereas asymptomatic cysts can be benign, malignant, or premalignant. Pancreatic cystic…
Introduction Cancer continues to be a major health problem, as one in four deaths in the United States is attributed to cancer. However, we continue to see incremental improvements over time, with the relative 5-year survival rate for cancer in…